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ABSTRACT
An Exploration of Factors that Impact Uptake of Human Papillomavirus Vaccines
David Samuel Redd
Department of Microbiology and Molecular Biology, BYU
Master of Science
Introduction
The discovery and continued development of vaccines is arguably one of the most
important innovations in human history. Vaccination greatly reduces the worldwide incidence
and transmission of diseases, preventing permanent injury and premature death. Mass
vaccination campaigns have led to the eradication or partial eradication of severe infectious such
as smallpox and polio, have reduced childhood mortality, and has led to an overall increase in
average health in the human population globally.
Despite the documented benefits of vaccination, vaccine hesitancy is increasing, and the
uptake of some vaccines is low. Vaccines have been so successful at preventing disease that
portions of the population are now more afraid of the possible side-effects of vaccines then they
are of the serious symptoms and maladies that vaccines prevent. Vaccine hesitancy is a serious
concern for the global medical community. The incidence of infectious disease is inversely
proportional to vaccine uptake; as fewer people are vaccinated against preventable diseases, the
frequency at which people get sick increases. A reduction in vaccination rates due to vaccine
hesitancy reduces herd immunity, which increases the risk for the whole population, especially
immunocompromised individuals who are unable to receive vaccines.
Vaccines that protect against high-risk strains of Human Papillomavirus (HPV) have
recently been developed and released to the worldwide population. High-risk HPV strains can
cause persistent infection and various cancers. Although HPV vaccines have been extensively
tested and are recommended by the Centers for Disease Control and Prevention and the World
Health Organization, uptake among some demographics is low. Understanding what factors
impact HPV vaccine hesitancy can guide the design of effective interventions which can increase
vaccine uptake. High HPV uptake will lead to a reduction of HPV associated cancers and reduce
the transmission of high-risk subtypes.
Research Significance
Vaccine hesitancy is a growing challenge for the medical community and could
potentially put global health at risk by undermining 200 years of progress towards eliminating
infectious diseases. A better understanding of what factors impact vaccine hesitancy allows
public health professionals to design better policies and interventions policies and helps primary
care providers better address concerns the concerns of their patients. Better understanding of the
factors which cause vaccine hesitance can be used to tailor education about vaccines. This leads
to higher vaccine uptake and better community health overall.
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Methodology
Electronically distributed surveys and statistical analysis were the primary tools used in
this research. Surveys were used to generate data from a sample population, including:
demographic factors, attitudes towards vaccination, and intent to vaccinate against HPV. Barriers
to HPV vaccine uptake and factors that impact HPV vaccine acceptance were identified through
statistical analysis, including confirmatory factor analysis, structural equation modeling,
regression, and univariate analysis.
Findings
We found that general attitudes toward vaccination had the greatest impact on the intent
of parents to vaccinate their children against HPV. Parents who view vaccination positively
intend to vaccinate their children against HPV or have already vaccinated their children against
HPV. Parents who are somewhat unsure about vaccines are more hesitant about vaccinating their
children against HPV. Knowledge about HPV increases intent to vaccinate. We found that
traditionally religious parents who felt that religious adherence provided some protection against
HPV were more hesitant about HPV vaccinations. We found that both a religious-focused
intervention and an education-focused interventions increased parental intent to vaccinate more
than a control intervention.
Our study of Utah residents confirmed our earlier findings that general attitudes toward
vaccination had the greatest impact on the intent of parents to vaccinate their children against
HPV. Our study also confirmed that knowledge about HPV increases intent to vaccinate. We
found that high religious practice negatively impacts parental intent to vaccinate. Cautious sexual
attitudes also negatively impact intent to vaccinate against HPV. High religious practice is
correlated with cautious sexual attitudes which explains the negative impact of high religious
practice on intent to vaccinate.
The findings of this research work will be used to inform future religious and educational based
interventions in Utah and beyond.

Keywords: vaccination, vaccine hesitancy, vaccine acceptance, Human Papillomavirus, HPV,
Utah, Christian, religion
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Introduction
1. History of Vaccinations
1.1 Variolation
Vaccines are a relatively modern invention, however, attempts to prevent disease through
controlled exposure has been practiced for hundreds of years. Variolation, the practice of
deliberating inoculating uninfected persons with infectious materials, was practiced in Africa,
Asia, and the middle east as a protective measure against smallpox. The practice was discussed
in scientific correspondences throughout Europe and England, but the practice was not actively
adopted [1]. Variolation was popularized by lady Mary Wortly Montagu who learned of the
practice in the ottoman court where her husband served as an ambassador. Lady Montague had
her young son and daughter inoculated in an effort to protect them against smallpox. Upon
returning to London Lady Montague strongly advocated for the procedure. Although Variolation
reduced the mortality rate of smallpox infection the practice was not without risk. Variolation
could cause serious illness or death, it could trigger a smallpox outbreak because recently
inoculated patients were infectious, and a constant supply of infected individuals was necessary
to provide inoculation material [2].
1.2 Edward Jenner and the Discovery of Smallpox Vaccination
The practice of vaccination was developed by Edward Jenner, an English physician in the
late 1700’s. As a teenager Jenner was apprenticed to a local physician. He continued his studies
at St. Georges Hospital in London, where he was mentored by the renowned surgeon Sir John
Hunter. After completing his studies Jenner declined a position at the hospital and returned to the
countryside where he started practicing as a physician. Jenner, like other physicians of his day,
became an expert at administering variolation [3]. As a country physician, Jenner observed that
some patients who had previously contracted cowpox were resistant to receiving variolation.
Upon further inquiry he learned that local dairy workers believed that cow pox was preventative
of smallpox. While contemplating the fact that cowpox infection was preventative of smallpox.
Jenner concluded that cowpox could be deliberately transmitted from one person to another as a
protective mechanism against smallpox [4].
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In order to test his theory and convince his physician colleagues that cowpox inoculation
could protect against smallpox, Jenner performed an inoculation experiment. In May 1796,
Jenner inoculated an 8-year-old boy named James Phipps with material from the lesions on the
hands of Sarah Nelms, a dairymaid who had recently contracted cowpox. Phipps developed
symptoms due to the inoculation but recovered within a few days. Jenner inoculated Phipps with
fresh smallpox mater a couple of months after the initial cowpox inoculation. Phipps did not
develop symptoms from the smallpox inoculation, which showed that cowpox inoculation did
prevent smallpox [4].
Following the successful experiment with Phipps, Jenner began inoculating other people
and recording the results [5]. Jenner submitted a manuscript to the royal society which contained
his research and observations about the protective action of cowpox and detailed his
experimental inoculation of James Phipps. The manuscript was returned unread by the royal
society. Jenner preformed additional experiments, reworked the manuscript and published it at
his own expense [3]. Jenner chose to call his new inoculation procedure vaccination, derived
from the Latin words for cow Vacca and for cowpox Vaccinia [4]. All protective inoculations
were later named vaccines in honor of Jenner’s pioneering work.
Edward Jenner was not the first person to notice that contracting cowpox conveyed
protection against smallpox, this was an acknowledged fact among dairy workers. He was also
not the first person to deliberately inoculate someone with cowpox with the intent of preventing
smallpox. Benjamin Jesty a farmer in Dorset, performed a cowpox inoculation on his wife and
two sons in 1774, 22 years before Edward Jenner attempted it [6]. During a smallpox outbreak
Jesty inoculated his wife Elizabeth and his two sons, with material from lesions on the udders of
a cow that was exhibiting cowpox symptoms. His wife and sons developed mild symptoms
including a fever but soon recovered. Elizabeth and Jesty’s two sons remained free of smallpox
despite frequent exposure to disease [6]. It is unclear whether Jenner was aware of Jesty’s
experiment. Jenner is revered not for being the first to attempt a cowpox inoculation, but because
he documented his observations and experiments and then publicized his findings [5]. Through
experimentation and careful documentation, Jenner showed that the protective effects of cowpox
exposure were not just a superstition of dairymaids and farmers but was a viable method of
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preventing smallpox on a grand scale. After his discovery Jenner worked tirelessly to promote
his findings and provide the world with a ready supply of cowpox cultures for vaccination.
1.3 Louis Pasteur
Louis Pasteur, a French microbiologist, and chemist built on Edward Jenner’s pioneering
vaccination work. Pasteur’s work showed that vaccines against most microbial diseases could be
created in laboratories by deliberately weakening pathogenic agents. His work on rabies also
showed that vaccines could be used therapeutically to treat patients who had already been
exposed to a pathogen [7].
Pasteur’s early work was focused on fermentation and spoilage due to bacterial
contamination. While studying fermentation using a microscope, he observed structures smaller
than yeast (Bacteria) which he concluded were responsible for the spoilage [8]. Pasteur’s
extensive microbiology experience was essential when he began working with fowl cholera, an
endemic disease that was devastating domestic chicken production in France. Pasteur was able to
isolate Pasteurella multocida, the bacteria that causes fowl cholera. By culturing the bacteria
repeatedly Pasteur was able to attenuate the bacteria, which could then be used to vaccinate
chickens against fowl cholera [9]. The method that Pasteur used to create the vaccine is more
important than the vaccine itself, because it showed that vaccines for various diseases could be
created by deliberately weaking pathogens by passaging them in culture.
After successfully developing a fowl cholera vaccine, Pasteur began work on developing
an anthrax vaccine. Bacillus anthracis was discovered by a German physician and microbiologist
named Robert Koch. Through a series of experiments Koch also found that bacillus anthracis
could form spores which allowed the bacteria to persist in soil [10]. Soon after Koch announced
the discovery of Bacillus anthracis, Pasteur repeated some of Koch’s experiments in an attempt
to develop a vaccine. Pasteur found that the bacteria retained its pathogenicity even after being
passaged 100 times. Pasteur had Previously used this method to create a fowl cholera vaccine,
but his work with anthrax was unsuccessful. Jean Joseph Henri Toussaint a veterinarian who
was also working with anthrax successfully created a vaccine by heating a culture for 10 at 55C
killing the bacteria [7].
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Pasteur’s most innovative and controversial work is the development of a rabies vaccine.
Rabies can infect most mammals including humans and is extremely deadly. Lyssavirus which
causes rabies is transmitted by the bite of an infected animal. The virus infects the nerves at the
bite site, where it is transmitted to the central nervous system and from there to the brain where it
causes neurological symptoms and death [11]. Due to long incubation period of rabies as the
virus travels up the nerves to the brain it was suggested that a therapeutic remedy could be used
after infection but before the onset of symptoms [7]. Pasteur and Émile Roux a physician and
frequent collaborator, attempted to attenuate the virus by passaging it through various susceptible
species. They developed a vaccine by drying the nervous tissue of rabbits infected with rabies.
The dried spinal cords were emulsified and injected using progressively newer samples which
generated immunity in the test subjects [7]. Pasteur and Roux were able to successfully vaccinate
dogs using this method [12].
Although Pasteur’s vaccine protected dogs against rabies, he also wanted to protect
humans against the disease. He wrote to Dom Pedro II the emperor of Brazil, whom he had
previously befriended, asking for permission to test his vaccine on convicted prisoners. Dom
Pedro II denied Pasteur’s request [13]. The opportunity to test the effectiveness of the rabies
vaccine on Humans arose sometime later. A 9-year-old boy named Joseph Meister was brought
into the clinic of Dr Joseph Grancher, one of Pasteur’s closest collaborators. The boy had been
bitten multiple times by a rabid dog. Pasteur agreed to vaccinate the child because otherwise he
would likely die. The boy was given 12 consecutive injections of desiccated rabbit spinal cord.
The experiment was successful, and the boy survived [8]. Pasteur and his colleagues developed
new methods for producing vaccines and demonstrated that vaccines can be used both
protectively before exposure, and the therapeutic after exposure to a pathogen.
1.4 Development of Toxoid Vaccines Against Tetanus and Diphtheria
The next major discovery in the field of vaccination was the development of Tetanus and
Diphtheria vaccines. Emil Von Behring and Shibasaburo Kitasato preformed a series of
experiments with the recently discovered bacterial pathogens Clostridium tetani and
Corynebacterium diphtheria the pathogens responsible for tetanus and diphtheria. They reported
that whole blood, or cell-free serum from rabbit’s immune to C. Tetani due to a previous
inoculation would protect mice infected with a lethal dose of tetanus [14]. They also reported
4

that adding serum from immunized rabbits to a culture of C. tetani would block its lethality when
injected into mice [14]. They concluded there was a component in the blood of tetanus-immune
rabbits that could destroy the tetanus toxin. They also concluded that these properties were stable
and remained effective even in other animals [15]. A week after Kitasato and von Behring
published their results, von Behring presented similar research on diphtheria showing that serum
from an immune animal protected against diphtheria toxin [15]. Both Clostridium tetani and
Corynebacterium diphtheria create toxins that harm the infected host. Kitasato and von
Behring’s research led to the development of toxoid vaccines which contain a chemically
modified toxin which elicits an immune response and causes the body to produce neutralizing
antibodies without harming the host.
1.5 Adjuvant Development
Researchers were beginning to understand that vaccines provided immunity by introducing
antigens that trained the immune system to recognize and destroy pathogens. Various methods
were used to attenuate pathogens so that could be safely used in vaccine preparations. Effective
vaccines need to strike a balance between eliciting a strong enough immune response to convey
immunity, and not causing undue harm to the individual. Gaston Ramon, a French veterinarian,
noted that tetanus and diphtheria anti-sera produced from horses was higher if the animal had an
abscess at the injection site. He injected breadcrumbs, tapioca, and starch to create sterile
abscesses and thus increase anti-sera production [16]. Around the time of Ramon’s discovery,
Alexander Glenny a British immunologist noted that aluminum salts enhanced an immune
response. While concentrating and purifying diphtheria toxoids Glenny and his Collogues used
potassium aluminum sulfate. They found that the vaccine prepared with aluminum salts
produced a stronger antibody response then the vaccine prepared only with soluble toxoids [17].
The starches used by Ramon and the aluminum salts observed by Glenny acted as adjuvants,
substances that enhance the body’s immune response to an antigen. Adjuvants stimulate the
immune system which produces strong and lasting immunity without causing lasting harm.
Aluminum salt adjuvants have been used safely for 90 years and are used in vaccines today [18].
1.6 Founding of the World Health Organization, and Center for Disease Control
Although vaccines are designed to be as safe and effective as possible, due to how
diverse the human population is the effectiveness of vaccines can vary by individual. In addition,
5

due to immune complications some individuals cannot safely receive vaccines. The best way to
protect those people who cannot receive a vaccine or for whom a vaccine does not convey
adequate protection is to achieve a high rate of vaccination in the rest of the population. A high
vaccination rate reduces the ability for diseases to spread through the population and protects
individuals who were not vaccinated, this is called herd immunity. There have been various local
efforts and mandates to promote vaccination since their discovery. Edward Jenner worked
tirelessly to promote and distribute the smallpox vaccine after it’s discovery. Louis Pasteur
founded the paster institutes to research and distribute vaccines. Vaccination has been mandated
by various armies to protect soldiers from disease outbreaks. The first national and international
vaccination campaigns were implemented in the early to mid 1900’s. In addition to vaccine
campaigns organizations were founded that promoted vaccination, monitored vaccination efforts,
and set vaccination guidelines. The center for disease control and Prevention (CDC), the national
public health agency for the United states, was founded in 1946 in Atlanta [19]. The World
Health Organization (WHO) which is the United Nations agency responsible for global health,
was founded shortly after in 1948 [20]. Health organizations and vaccine campaigns have helped
increase vaccine uptake which has led to a major reduction in the transmission of vaccine
preventable diseases.
1.7 Elimination of Smallpox Through Global Campaign
One of the first major vaccination programs that the WHO launched was the global smallpox
eradication program in 1967. The program was extremely successful, and smallpox was
completely eliminated. The last recorded case of smallpox occurred in Somalia in 1977, the
WHO declared that smallpox had been eradicated in 1980 [21]. There are three factors that
made smallpox elimination possible according to Donald Henderson who led the effort.
Smallpox is strictly a human disease with no animal reservoir; therefore, it couldn’t be
reintroduced from another species. Smallpox could be easily diagnosed due to the characteristic
rash that it produced. An inexpensive, heat-stable, and effective vaccine was produced that was
easy to use [22]. To date, smallpox is the only human disease that has been totally eliminated
through vaccination, but there are other diseases such as polio that could be eliminated by
continued vaccination effort.
1.8 Development of Subunit Vaccines and Treatment of Polio
6

The development of the Polio vaccine made subsequent vaccination efforts possible.
Poliomyelitis is enterovirus that can cause a fever, sore throat, and in more serious cases
paralysis and death. Polio is transmitted through oral ingestion; it multiplies in the alimentary
mucosa before moving into the blood. From the blood the virus can invade the central nervous
system and cause paralysis due to neuron destruction [23]. The disease was first characterized in
the mid 1800’s. At the beginning of the 20th century Polio outbreaks became more frequent and
sever in Europe and the United States [24]. A few early vaccines were developed and tested but
were found to be ineffective or dangerous and were discontinued. The first polio vaccine that
experienced widespread success was developed by Dr Jonas Salk, an American physician and
virologist. Salk and his team formulated a vaccine using formaldehyde to inactivate the virus
without destroying its antigenic properties. After extensive testing to establish safety and
efficacy, Salk’s vaccine was widely distributed nationally and internationally [25]. While Salk
was developing his vaccine, Dr Albert Sabin, and Dr Hilary Koprowski had also began working
on developing a polio a vaccine. Sabin used a different approach then Salk. He cultured a
trivalent live attenuated vaccine by passaging the virus in vitro then in vivo to reduce its
virulence [24, 26]. Because Salk’s vaccine was already in use in the United States, Sabin tested
his vaccine in other countries including the Soviet Union where millions of doses were given to
children. Shortly after the onset of mass vaccination with Salk’s vaccine, some patients
developed paralysis in the limb where the vaccine was administered. During preparation in the
cutter and Wyeth laboratories the virus was inadequately deactivated. This led to the recall of
thousands of doses and a decrease in trust in the vaccine [25]. Due to the complications with
Salk’s vaccine and the success of Sabin’s vaccine in testing in the Soviet Union, Sabin’s vaccine
received approval for use in the United States and was instrumental in the elimination of polio in
most of the world [25, 26].
Live Attenuated vaccines, Inactivated vaccines, and toxoid vaccines have all been used to
effectively treat various diseases, but each method of vaccine preparation has limitations. The
incomplete inactivation of some batches of the Salk Polio vaccine is a well-known example of
the limitations of inactivated vaccines. If vaccines are inadequately attenuated or inactivated,
they can cause disease in patients. Attenuated live vaccines are unsuitable for
immunocompromised individuals. Toxoid vaccines only work for a small subset of diseases
where the pathogen produces toxins. Due to disadvantages mentioned above a new class of
7

vaccine was developed called a subunit vaccine. Subunit vaccines only contain components or
antigens to stimulate the immune system, rather than whole attenuated or killed organisms.
These vaccines are easier to produce, can be used against a wide range of pathogens, and cannot
cause disease. The main downside of subunit vaccines is that they do not illicit as strong of an
immune response as other vaccines, therefore booster shots are required. Subunit vaccines were
made possible due to major advances in molecular biology and microbial genetics in the 1950’s
and 60’s. The first subunit vaccine that was developed was a Hepatitis B vaccine developed by
Baruch S Blumberg.
Baruch S. Blumberg, an American physician discovered an antigen he termed the
Australian antigen (AuAg) named for the patient it was isolated from. Research later revealed
that AuAg was the surface antigen of the viral envelope of the Hepatitis B virus (HBV) [27]. The
first HBV vaccine was created by purifying the Hepatitis B antigen from the blood of infected
donors. Antigen purification is a fairly involved process with a series of steps including
Ultracentrifugation, pepsin digestion, denaturation, gel filtration, and treatment with
formaldehyde [28]. Purifying a viral antigen was a novel approach to vaccine creation, it was
also somewhat controversial because the blood was harvested from infectious patients who may
have had HIV or other bloodborne pathogens. The lengthy filtration steps deactivated or
destroyed all known pathogens making the vaccine safe for use. The Vaccine was licensed for
use in The United States and France after extensive safety and efficacy testing [28]. Due to the
high cost of producing the blood-derived HBV vaccine, it was eventually withdrawn and
replaced by a vaccine that was produced by making viral antigens in recombinant yeast
developed by Maurice Hillman.
1.9 mRNA Vaccines and Rapid COVID-19 Vaccine Development
The newest type of vaccine is mRNA based. The advantages of mRNA vaccines are that
they can be developed extremely quickly, are cost effective to produce and safe to administer.
An antigenic protein is encoded on mRNA which is translated by the ribosomes in cells to form
proteins. These proteins are recognized by the immune system conveying immunity. mRNA is
rapidly degraded within the body, so a polymer is used which protects the mRNA from
degradation until it can be translated. Exogenous mRNA is immunostimulatory acting as a
natural adjuvant [29]. The first major use of mRNA-based vaccines was developing vaccines for
8

the novel corona virus SARS-CoV-2. COVID-19 emerged in the Wuhan Provence of China in
late 2019. The disease quickly spread around the world and was declared a global pandemic by
the WHO in March 2020. Two mRNA-based vaccines were rapidly developed by Moderna
Biotechnology and a through a BioNtech and Pfizer collaboration. The vaccines were developed,
manufactured, tested, and approved for use in less than a year [30]. Millions of vaccines were
distributed worldwide, reducing the incidence and severity of COVID-19 infections. The speed
at which the vaccines were developed illustrates the advantages of mRNA-based vaccines.
Table 1: Vaccine Types
Vaccine Type:
Live attenuated

Mechanism:
A weakened
(attenuated) bacteria or
virus

Advantages:
Creates strong-long
lasting immune
response with minimal
doses

Disadvantages:
Requires refrigeration, may cause
complications in immunodeficient
individuals

Killed whole organism

non-infectious residue
of killed pathogen

Safer for
immunodeficient
individuals

Requires refrigeration, provides
weaker immune response then
attenuated vaccine

Purified protein or
polysaccharide

Purified protein or
polysaccharide
subunits

Elicits strong immune
response, safe for
immunodeficient
individuals

May require subsequent "booster"
doses to maintain efficacy

Genetically engineered

Protein or
polysaccharide
subunits produced by a
recombinant organism

Elicits strong immune
response, safe for
immunodeficient
individuals

May require subsequent "booster"
doses to maintain efficacy

mRNA vaccine

pathogenic antigen
encoded on RNA and
produced by host

Elicits strong immune
response, safe for
immunodeficient
individuals

Requires refrigeration, Longlong
term efficacy unknown
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2. The rise of Vaccine Hesitancy
2.1 Vaccine Hesitancy is a Global Health Concern
Although vaccines have proven to be a safe and effective method of preventing disease,
there have been concerns about their use almost since their inception. Vaccine hesitancy has
evolved over time based on misconceptions, fears, and changes in public perceptions. In 2019
the WHO listed vaccine hesitance as one of the top ten threats to global health [31]. Vaccine
hesitancy is defined as a delay or refusal to vaccinate despite availability of vaccination. Vaccine
acceptance is the norm in the majority of global populations, however, a smaller subset of the
population delay vaccination or refuse certain vaccines [32].
2.2 Vaccine Hesitancy Through History
Vaccine hesitancy has existed almost as long as the practice of vaccination. Variolation, a
preventative practice used before the development of the smallpox vaccine, killed, or caused
other diseases (e.g., tuberculosis and syphilis) in 2% to 3% of recipients [4]. Benjamin Jesty, the
first person recorded to have used a cowpox inoculation to protect against smallpox, was
ridiculed by his neighbors after inoculating his wife and children [6]. Jenner’s vaccine work was
initially met with skepticism, and some people declared that vaccination was contrary to Gods
will [33]. The polio vaccine developed by Jonas Salk caused limb paralysis in a number of
patients; During the manufacture of the vaccine the virus in some batches wasn’t adequately
neutralized and remained virulent. Because everyone is different, vaccines can sometimes cause
side effects despite being prepared correctly and undergoing extensive safety testing. Common
side effects that occur after vaccination are pain or swelling at vaccination site, mild fever, chills,
fatigue, headache, as well as muscle and joint aches [34]. Most of these symptoms are caused by
the immune system responding to the vaccine. In rare cases vaccines can cause severe side
effects including difficulty breathing, swelling of the face and throat, an elevated pulse, a severe
rash across the whole body, dizziness and weakness, and in extreme cases death [34]. Although
vaccines are safe for the vast majority of people there is a small risk of side effects. Vaccines are
orders of magnitude safer then contracting the diseases they are designed to prevent. Fears about
vaccine side effects, both real and imagined, can be magnified by social media causing far more
concern about vaccination then is actually warranted.
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2.3 Disproven link Between MMR Vaccination and ASM
One of the most widespread vaccine concerns is the purported, but disproven, hypothesis
that vaccination causes autism. This unsubstantiated concern arose when Andrew Wakefield, a
British gastroenterologist and collaborators, published a paper that described 8 children whose
first symptoms of Autism spectrum disorder (ASD) manifest within 1 month of receiving the
measles-mumps-rubella (MMR) vaccine. Wakefield postulated that the MMR vaccine caused
inflammation which affected development and lead to the onset of ASD [35]. There were
problems with the study including a lack of control subjects and a sample population too small
(n=12) to preclude that the development of ASD symptoms following MMR vaccination was not
merely coincidence [24, 36]. Soon after the paper was published, epidemiological studies were
conducted and published which refuted the implied link between ASD and vaccination [24, 36].
10 of the 12 authors on the paper retracted their interpretation of the data stating that “no causal
link was established between MMR vaccine and autism as the data were insufficient” [37]. In
2010 The Lancet, the journal that originally published the paper by Wakefield et al., retracted the
paper stating that “several elements in the paper were incorrect, contrary to the findings of the
earlier investigation” [38]. Wakefield et al. were later found guilty of failure to disclose financial
interests, falsifying facts, and deliberate fraud [24, 39]. In a study conducted on parents of under
vaccinated children in Utah, the most commonly reported concerns regarding immunization
safety were autism, immune system overload, and the potential of serious adverse reactions. This
study indicates that parental fear of ASD development impacts vaccine hesitancy [40]. Although
the unsubstantiated link between vaccination and ASD has been thoroughly disproven, vaccine
hesitancy has increased due to concerns about developing ASD, and there has been a drop in
vaccine uptake.
In addition to the risks associated with early vaccines and flawed information from
spurious studies, there are a myriad of other factors that influence vaccine hesitancy. Lack of
access to accurate information, and the spread of misinformation through social media has a
significant negative impact on confidence in vaccines. Misinformation can quickly spread
through social media, making it difficult to differentiate between fact and fabrication [41]. In
addition to the rapid spread of misinformation, changes in the medical system have greatly
constrained the time doctors have per appointment, making it difficult for them to educate and
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address the concerns of their patients. [41] The low incidence of contagious diseases due to
vaccination has led to the perception that the risk posed by these diseases is also low. [42] Due to
the success of vaccination in preventing most major disease outbreaks, fear has shifted away
from vaccine-preventable diseases to fear of the vaccines themselves. [43]
3. Human Papillomavirus
3.1 HPV Biology and Replication
Human Papillomaviruses are a family of over 150 related, small non-enveloped, double
stranded DNA viruses [44, 45]. HPV infects cutaneous and mucosal stratified epithelium cells
that form the epidermis and the linings of the genitals and upper respiratory tract. The virus
enters the epithelium through microlesions where it infects basal epithelial cells. The virus
begins to replicate with in the infected cells. As the infected basal cells divides, copies of the
viral genome are distributed into both daughter cells. One of the daughter cells migrates up
through the epithelium where it starts to differentiate while the other daughter cell remains part
of the basal epithelium where it continues to replicate. As the daughter cell travels up through the
epithelium, the virus halts differentiation because a fully differentiated epithelial cell lacks the
cellular machinery necessary for viral DNA synthesis. The virus stimulates G1 to S-phase
progression to while inhibiting differentiation making an environment where viral DNA, and
capsid proteins can be produces [46]. The viral DNA is replicated as the cell passes through the
Stratum Granulosum and viral particle assembly occurs within the Stratum Corneum. Once the
infected cell reaches the surface it can be sloughed off allowing viral transmission to other
individuals. The modulation of the cell can increase cell proliferation creating growth called
papilloma, or warts [46]. The virus can also cause oncogenic mutations, which eventually lead to
the development of cancer [47].
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Figure 1: Epithelium Cross Section Illustrating HPV Replication. 1 Basal epithelium - the first
cells infected. 2 infected cells migrating through epithelium. 3 infected cells undergo DNA
replication in the Stratum Granulosum. 4 infected cells are sloughed off. (Created using
Biorender)
3.2 HPV Transmission
HPV is usually transmitted through direct skin-to skin or skin-to-mucosa contact. HPV
strains that infect the mucosal membranes are usually transmitted through sexual intercourse, but
can also be transmitted through other types of sexual contact [45]. Though less common then
skin-to-skin transmission, HPV can be transmitted on surfaces or medical implements [48].
HPV is very durable and resists most commonly used disinfectants [49]. HPV is the most
commonly sexually transmitted infection in the United States. An estimated 80% of sexually
active individuals will contract HPV sometime during their lifetime [45]. HPV has-co-evolved
with humans for millions of years and is therefore well adapted. HPV infections are usually mild
and cause minimal symptoms or are completely asymptomatic [44]. Most HPV infections are
cleared within one to two years by the immune system; persistent HPV infection is strongly
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associated with an increased risk of genital warts and cancer [45]. There are approximately 40
HPV strains that are sexually transmitted. Oncogenic HPV strains are classified as high-risk
(16,18, 31, 33, 35, 39, 45, 51, 52, 58). Non-oncogenic strains that cause genital warts are
classified as low risk (6,11, 40, 42, 43, 44, 54). HPV strains 16 and 18 are the most dangerous
strains, they cause approximately 70% of all HPV associated cancers [45]. Due to the prevalence
of HPV transmission and the danger presented by high-risk strains, vaccination is an important
health safety measure that protects against the most pernicious HPV strains.
3.3 Development of HPV Vaccine
Two HPV vaccines were developed and released around the same time. The first HPV
vaccine to be released was Gardasil, a quadrivalent recombinant vaccine produced by Merck &
Co. Gardasil is protects against HPV subtypes 6,11,16, and 18, received FDA approval, and was
released in 2006 [50]. The second HPV vaccine to be released was Cervarix, a bivalent vaccine
developed by GlaxoSmithKline. The vaccine provides protection against subtypes 16 and 18 and
received FDA approval in 2007. In 2014 Merck released Gardasil 9, a nine-valent vaccine that
provides protection against 6, 11, 16, 18, 31, 33, 45, 52, and 58. Cervarix was voluntary
withdrawn from the market in 2016. Gardasil and Cervarix are both purified protein vaccines
which contain virus-like particles (VLP) of the major papillomavirus capsid protein L1. The
major capsid protein is produced through recombinant expression, and then purified. The
structural proteins self-assemble into highly immunogenic VLP’s which mimic virions [51]. In
addition to VLP’s the Cervarix vaccine contains Monophosphoryl lipid A and aluminum
hydroxide as adjuvants, and Gardasil and Gardasil 9 contain aluminum hydroxide as adjuvants
[52].
3.4 HPV Vaccine Hesitancy
Although safe and effective vaccines against HPV have been developed, uptake is low.
The Advisory Committee on Immunization Practices (ACIP) recommends that all children aged
11 to 12 receive HPV vaccination. Despite ACIP recommendations, vaccination rates have
remained low. In 2013 57.3% of girls and 34.6% of boys initiated an HPV vaccination series.
Less than 40% of girls and less than 15% of boys completed the series showing rates well below
the target of 80% [53]. There are many barriers that could prevent parents from vaccinating their
kids against HPV. Some barriers that have been identified are: lack of knowledge about HPV,
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financial concerns, parental attitudes, lack of information about HPV vaccines, concerns about
the vaccines’ effect on sexual behavior, and low perceived risk of HPV infection [54, 55]. A
major barrier that could negatively impact HPV vaccine uptake is concerns about the safety of
HPV vaccines. In recent years the number of parents who have declined HPV vaccination for
their child due to safety concerns has increased despite reports of serious health complications
after vaccination being consistently rare [56].
There are many demographic factors that can influence HPV vaccine uptake. Europe has
a higher HPV vaccine uptake then the United States, and England and Scotland have higher rates
then continental Europe [57]. England and Scotland’s high vaccine uptake rate is in part due to in
school vaccination programs, which most other European countries lack. Australia also has a
school-based vaccination program and consequently high HPV vaccine uptake rate. Without a
school-based vaccination program, vaccine uptake in the United States is dependent on parents
and primary care providers [57]. Multiple studies have shown that religious and spiritual beliefs
impact HPV vaccine uptake [58, 59]. Highly religious individuals who identify as Christian may
feel that their or their children’s risk of contracting HPV is low due to religious values such as
abstinence before marriage. Some religious individuals may also object to some ingredients in
vaccines or how certain vaccines are manufactured. Understanding what factors negatively affect
vaccine uptake would aid primary care providers and Public Health as they address concerns
which would improve HPV uptake.
Geography is another factor that influences HPV vaccine uptake. For the past 5 years
Utah has had the one of the lowest HPV vaccination rates in the country [60]. There are many
factors that could influence Utah’s low vaccination rate. A recent study of Utah health care
providers found parental misconceptions to be the greatest barrier to HPV vaccination [59]. Utah
also has a highly religious population which could have an impact on HPV vaccine acceptance.
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Figure 2: National HPV Vaccination Rates. This figure shows vaccination rates by state for the
last 5 years. Darker blues indicate lower vaccination rates. Utah has one of the lowest rates and is
consistently below 50%
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Chapter 1
Effects of Religious Practice and Teachings About Sexual Behavior on Intent to Vaccinate
Against Human Papilloma Virus
David S. Redd, Jamie L. Jensen Savannah J. Hughes, Kendall Pogue, Chantel D. Sloan-Aagard,
Dashiell S. Miner, Jessica D. Altman, Triston B. Crook, Lydia Zentz, Ruth J. Bodily, and Brian
D. Poole,
Abstract:
Human Papillomavirus (HPV) is the most common sexually transmitted infection in the
United States. Most infections are mild and clear without treatment in 1 to 2 years. Some HPV
strains result in persistent infection which can cause various cancers including cervical, penile
anal mouth and throat cancers. Vaccines have been developed which provide protection against
the highest risk HPV strains. Despite HPV vaccines having been proven to be safe and effective,
uptake has been low. Religiosity has been negatively correlated with HPV vaccine uptake in
some studies. It is hypothesized that religiosity and Christian religious affiliation could impact
parents’ decision to vaccinate their children against HPV via teachings and beliefs about sexual
behaviors. A survey was distributed to participants to determine what factors, including
religiosity and views about sex, impacted HPV vaccination. The survey results (n=442) were
analyzed using confirmatory factor analysis, structural equation modeling, and univariate factor
analysis. The association between religious practice and vaccine attitudes were complex, with
religious practice slightly positively correlated with provaccine attitudes and vaccine knowledge,
but also with the belief that religious adherence to expectations surrounding sexual behavior will
protect children from HPV infection, and more negative views towards vaccines in general.
Keywords: Human Papillomavirus; Sexually transmitted infection; Vaccine Attitudes; Vaccine
hesitancy; Christian religious views
1. Introduction
Human papillomaviruses (HPV) are a family of human, nonenveloped, double-stranded
DNA viruses [61]. HPV is the most commonly sexually transmitted infection in the United
States. It is estimated that over 80% of sexually active individuals will contract HPV sometime
during their lives [45, 61]. HPV is generally transmitted through skin-to-skin, or sexual contact,
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where it infects cutaneous and mucosal epithelium [45, 46]. Most HPV infections do not cause
serious symptoms and resolve without treatment within 1 to 2 years [45]. Because HPV often
presents asymptomatically it can be passed unknowingly between sexual partners. Although
many HPV strains are not a serious concern, some strains can cause persistent infection which
can result in genital warts and cancer in mucosal membranes including cervical, anal, penile and
throat cancers. HPV is the primary causative agent of cervical cancer; HPV is responsible for
over 95% of cervical cancer cases. Oncogenic HPV strains are classified as high risk; strains 16
and 18 are the most dangerous causing 70% of HPV-associated cancers [46].
Due to the risk presented by persistent HPV infection and the cancers associated with it,
significant effort was made to develop a vaccine. Three vaccines have been approved by the
Food and Drug Administration (FDA) for use in the United States. Multiple studies have
determined that the three approved vaccines have an acceptable safety profile and are effective at
preventing high-risk HPV infection [62]. HPV vaccination is recommended for both males and
females ages 9 to 45 [63, 64]. HPV vaccines provide the best protection if administered before an
individual becomes sexually active. It is recommended that vaccination be administered during
the early teens, but it can be administered later [63, 65]. Vaccination efforts have been highly
effective at reducing incidence and transmission of strains covered by the vaccine [66]. It is
anticipated that cervical cancer could be completely eliminated in areas with high rates of
vaccine uptake [67].
Despite HPV vaccines having proven effectiveness and an acceptable safety profile, the
vaccination rate in the United States is low. Recent estimates of adolescent (ages 11-17)
vaccination coverage show that 41.9% of females and 28.1% of males have completed a
vaccination series [68]. The reported vaccination rates for young adults are even lower than
adolescents. The US department of Health and Human Services (HHS) estimates that in the
United States less than half of young adults (ages 18-26) have received an HPV vaccine dose and
only 22% have completed a vaccine series [69]. HPV vaccination rates are increasing in
teenagers but still fall below the vaccination target of 80%. HPV vaccination rates are also well
below the rates of other vaccines recommended for adolescents such as Tdap and MenACWY
[68, 69]. This indicates that the HPV vaccine is not being routinely recommended or
administered when other adolescent vaccines are administered. HPV vaccination rates of
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adolescents are closely monitored and studied, however there is less data on young adult
vaccination rates. A study looking at vaccination trends in the 2010 -2018 National health
interview survey found that participants who reported having at least one dose increased between
2010 and 2018 from 32% to 55% for females and from 2% to 34% for males. The study also
found that 4% of females and 3% of males initiated vaccination between ages 18 and 21. In
comparison 68.1% of adolescents have received 1 or more doses [70]. Young adults have more
control over health decisions than adolescents but may have less access to health care services,
may be unaware they did not receive the vaccine, or may not actively seek medical care because
they believe themselves to be healthy. If HPV vaccination series is not initiated as an adolescent,
the series is less likely to be completed [70]. There are many factors that could impact HPV
vaccine uptake including access to vaccination, health care provider recommendations, parental
attitudes, religiosity, risk of infection, vaccine mandates, or sexual activity.
Multiple studies have shown a negative correlation between religious affiliation and HPV
vaccine uptake [58, 59, 71]. In a study of female college students, the impact of
religiosity/spirituality on sexual decision making was assessed. Bivariate analysis showed that
sexual activity and religious/spiritual beliefs were independently associated with HPV vaccine
uptake. However only sexual activity was significantly associated with vaccination in this study.
After correcting for socio-demographic variables, sexual activity was found to fully explain the
relationship between religious/spiritual beliefs and HPV vaccination [58]. This could indicate
that the influence of religiosity on sexual behavior could impact HPV vaccine uptake. A national
study investigated factors that influence HPV vaccination initiation. Survey participants who
were sexually active and participated in religious services less than once a month were more
likely to report initiation of HPV vaccination [71]. Another study of young adults in Utah found
that participants who belonged to an organized religion were significantly less likely to have
received a provider recommendation, and to have initiated or completed an HPV vaccination
series [59]. Although these studies suggest that religiosity can have a negative impact on HPV
vaccine uptake, more research in this area is necessary.
Understanding the impact of religiosity, religious affiliation, and religious beliefs about
sexual behavior on whether parents decide to vaccinate their children is important, because HPV
vaccination is recommended for children in their early teens before the initiation of sexual
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activity. In a survey study of parents and caregivers of daughters it was found that parents who
frequently attended religious services were more likely to decline vaccination than their less
religious peers [72]. In a focus group study of rural parents, the impact of spirituality and
religiosity on HPV vaccination attitudes was investigated. It was found that religiosity and
spirituality influence health choices and play an integral role in the parents’ life. The study also
showed that parents in rural communities have restricted access to healthcare providers, therefore
the religious community could play a valuable role in encouraging parents to vaccinate their
children [73]. The previous studies show that the impact of religiosity and religious affiliation is
complex; religiosity can negatively impact parents’ decision to vaccinate children against HPV
but addressing religious concerns could also be an avenue to increasing vaccine acceptance. We
intend to explore the complex relationships found in these prior studies using Structural Equation
modeling to look at how variables influence each other in terms of intent to vaccinate against
HPV. The focus of this research is not on teachings about vaccination in church, which are
likely minimal, but on how factors associated with religiosity affect attitudes towards vaccines.
Since attitudes towards vaccines by the public can have a strong effect on public policy such as
vaccine mandates to attend public school, efforts to improve vaccine attitudes in this population
may have far-reaching effects.
The aim of this study was to determine how Christian religious activity and teachings
about sexual relationships affects willingness to vaccinate children against HPV. We
hypothesized that increased religious practice and stronger views about sexual relationships
being sinful would affect such factors as trust in medicine, attitudes towards vaccines in general,
belief that lifestyle protects against infection, and knowledge about vaccines and HPV. We
further hypothesized that these factors would influence intent to vaccinate children against HPV.
By understanding how these factors relate to each other, we hope to identify areas that can be
emphasized in public health messaging or other mechanisms to improve vaccine uptake in this
population.
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2. Materials and Methods
2.1 Survey of Christian Parents
Parents were invited to participate in a cross-sectional study by completing an online
survey designed to assess attitudes toward HPV vaccination, and Christian religious views and
affiliation. The survey was distributed electronically by Qualtrics (Provo UT) using their
nationwide survey panel. Inclusion criteria included self-identification as Christian and being the
parent of at least one child under the age of 11. Education level of the respondents was also used
to determine participation, to ensure conformity with the education proportions in the United
States as a reference population and to diminish sampling bias. For an optimal structural
equation model, 442 complete responses were recorded. Structural equation modeling is
recommended to have at least 20 respondents per factor [74]. With our 9 factors, we need at least
180 respondents, so our sample size is more than adequate. Furthermore, post-hoc analysis using
confirmatory factor analysis is effective at evaluating sample size [75], and our confirmatory
factory analysis showed excellent validity with our sample. Incomplete responses were not
provided by the surveying company. Quality control was performed using a timing method,
whereby any participant who spent less than half the mean time completing the survey was
rejected. The survey was open from April 9, 2021 to May 20, 2021.
2.2 Survey Description
The survey consisted of 10 sections. The first section was an informed consent page,
which included a short explanation of the survey which stated that attitudes toward the human
papillomavirus vaccine were being studied. Participants were told that participation was optional,
that the survey would take approximately 20 min to complete, that survey responses would be
used for research purposes, and that all responses would be kept anonymous. Respondents who
were willing to participate in the survey could accept the terms and conditions and continue with
the survey. Respondents who did not accept the conditions were thanked for their time and the
survey concluded. The study was carried out under the principles of the declaration of Helsinki.
The study received ethical approval from the institutional review board of Brigham Young
University (Protocol # E2021-052).
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The second section of the survey assessed demographic information including religious
affiliation, number of children, age, sex, race, education, political affiliation, and socioeconomic
status. The third section assessed participant views on the connection between sexual inactivity
due to religious beliefs and contracting HPV (Beliefs that Religious Adherence Protects Against
HPV). The fourth section assessed views towards vaccines in general (Positive Attitudes Toward
Vaccines) and the HPV vaccine in particular (Fear of HPV Vaccine Side-effects and Intent to
Vaccinate). The fifth survey section had questions evaluating participants’ knowledge about and
understanding of vaccines (Vaccine Knowledge) and HPV (HPV Knowledge). The sixth section
assessed participants’ religiosity (Religious Practice, Religious Influence, and Religious Hope).
The seventh section assessed how participants’ religious affiliation viewed vaccines (ProVaccine Religious Views). The eighth section assessed how religion influences participants’
views on sexual behavior (Religious Encouragement of Premarital Abstinence). The ninth
section assessed the parental/peer influence on sexual behavior (Parental/Peer Influence on
Sexual Behavior). The final section of the survey assessed participants’ trust in modern medicine
(Trust in Modern Medicine). The survey itself was checked for face validity by a virologist (Dr.
Poole), a specialist in biological education and religious influences (Dr. Jensen), and a public
health expert (Dr. Sloan-Aagard). Intelligibility was checked by at least two undergraduate
students. (The full survey can be found in the supplementary materials S1)
2.3 Confirmatory Factor Analysis and Structural Equation Modeling
To validate our survey, we used Confirmatory Factor Analysis (CFA) to confirm that the
questions included in our surveys accurately represented our latent variables; to test the
relationships between latent variables we performed structural equation modeling (SEM). Before
starting analyses, we cleaned and organized the data using SPSS statistics software (IBM 2021
Armonk, NY). Mplus software ver. 8 (Muthen and Muthen, 1998-2010, Los Angeles, CA) was
used to perform both CFA on the measurement portion and SEM on the structural portion of our
models. Each latent variable in the model was represented by three or more survey items. CFA
was performed with a request for modification indices. Items were removed until fit indices [root
mean square error approximation (RMSEA), comparative fit index (CFI), Tucker-Lewis index
(TLI), and standardized root mean square residual (SRMR) were acceptable. Instruments were
combined into a full measurement model to ensure fit before commencing structural modeling.
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SEM was performed on two hypothetical models comprised of validated latent variables and
income as a covariate in model A.
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Figure 1.1 Hypothetical Models Illustrating Components of Hypotheses: [A] We hypothesize
that religious practice and pro-vaccine religious views influence trust in modern medicine,
vaccine knowledge, and general positive attitudes toward vaccines, which in turn influence intent
to vaccinate children against HPV. [B] We hypothesize that religious practice and religious
encouragement of premarital abstinence influence beliefs that religious adherence protects
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against HPV and knowledge about HPV, which in turn influence intent to vaccinate. These
connections are illustrated visually in the models.
2.4 Univariate analysis
Univariate analyses were performed using Pearson’s correlation analysis. The Intent to
vaccinate score was derived by combining the items from section 4 of the survey. A score for
Belief in vaccine efficacy was generated by combining the scores for the questions “Vaccines are
more helpful than harmful” and “vaccines are effective at preventing disease.” A score for
Vaccine safety was generated by combing the responses to “Vaccines contain dangerous toxins”
and “Vaccines often have severe side effects.” These were then compared to the Intent to
vaccinate score using Pearson correlation. A score for General vaccine knowledge was generated
by scoring the responses to the questions “Smallpox has been eliminated because of mass
vaccination,” “Vaccines increase the risk for allergies,” “Unvaccinated children are more
resistant to infections,” “Routine immunizations can be given while a child is on antibiotics for
an ear infection,” “Current scientific evidence supports associations between vaccines and
chronic conditions such as autism or multiple sclerosis” and “The Food and Drug Administration
(FDA) approval process for vaccines is the same as that for other drugs and pharmaceuticals.”
These scores were compared to the Intent to vaccinate score using Pearson correlation.
3. Results
3.1 Characteristics of Study Respondents
We began analysis of the survey data by summarizing the baseline characteristics of the
study respondents (Table 1). The majority of respondents were between ages 26 and 45
(77.59%). Approximately three fifths (60.4%) of respondents identified as female and two fifths
identified as male (39.60%), none of the respondents identified as non-binary or third gender.
Most respondents identified as partnered (75.11%). Approximately half of the respondents have
two children (49.77%). The respondents were fairly well educated with over half (53.4%) having
completed at least an associate’s degree. Income was relatively evenly distributed. The three
most selected religious affiliation were Christian (non-denominational) (38.91%), Catholic
(30.77%) and Baptist (13.12%).
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Table 1.1: Cohort Characteristics
Date
Number
Percent of total responses
Age (n = 442)__________________________________________________________________________
18‐25
38
8.60%
26‐35
170
38.45%
36‐45
173
39.14%
46‐55
37
8.37%
Over 55
24
5.43%
Gender (n = 422)_______________________________________________________________________
Male
175
39.60%
Female
267
60.4%
rd
Non‐binary/3 gender
0
0%
Prefer not to answer
0
0%
Marital status (n = 442)__________________________________________________________________
Single
54
12.22%
Partnered
332
75.11%
Married
19
4.30%
Divorced
7
1.58%
Widow/widower
30
6.79%
Number of Children_(n = 442)____________________________________________________________
One
130
29.41%
Two
220
49.77%
More than Two
92
20.81%
Education_(n =
442)____________________________________________________________________
Have not finished high school
12
2.71%
Finished high school
115
26.02%
Some college
79
17.87%
Associate degree
53
12.00%
Bachelor’s Degree
84
19.00%
Post‐baccalaureate
99
22.40%
Income (n = 442)_______________________________________________________________________
Less than $5,000
14
3.17%
$5,000‐$9,999
7
1.58%
$10,000‐$14,999
14
3.17%
$15,000‐$19,999
11
2.49%
$20,000‐$29,000
43
9.72%
$30,000‐$39,999
36
8.14%
$40,000‐$49,999
32
7.24%
$50,000‐$59,999
38
8.60%
$60,000‐$74,999
39
8.82%
$75,000‐$99,999
55
12.42%
$100,000‐$124,999
49
11.09%
$125,000‐$149,999
48
10.86%
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$150,000 or more
56
12.67%
Specific Christian religious affiliation (n = 442)________________________________________________
Anglican/Episcopalian
4
0.90%
Baptist
58
13.12%
Catholic
136
30.77%
Christian (non‐denominational)
172
38.91%
Church of Christ/Disciples of Christ 7
1.83%
Congregational
3
0.68%
Jehovah’s Witness
4
0.90%
LDS (Mormon)
3
0.68%
Lutheran
4
0.90%
Methodist/Wesleyan
7
1.58%
Orthodox (Eastern)
4
0.90%
Pentecostal/Charismatic
15
3.39%
Protestant (Other)
20
4.52%
Reformed/Presbyterian
2
0.45%
Seventh‐day Adventist
1
0.23%
Other
2
0.45%

3.3. Confirmatory Factor Analysis
Confirmatory factor analysis showed that each latent variable fit the data well. CFA
models were run for each structural equation model (see Figure 1A & 1B), for the remaining
latent factors used for univariate analyses, and for the combined model. Two items were
removed from the latent variable, Positive Attitudes Toward Vaccines, due to lack of fit
(“Vaccines often have severe side effects”, and “Vaccines contain dangerous toxins”). The
survey section on attitudes toward the HPV vaccine was divided into two latent variables: Fear
of HPV Vaccine Side-effects that consisted of items 1, 4, and 5; and Intent to Vaccinate that
consisted of items 2, 3, 6, and 7. One item was removed from the latent variable, Vaccine
Knowledge, due to lack of fit (“Smallpox has been eliminated because of mass vaccination”).
Two items were removed from the latent variable, HPV Knowledge, due to lack of fit (“Only a
small minority of people will catch HPV during their lives” and “HPV causes cancer in women
but not men”). And one item was removed from the latent variable, Trust in Modern Medicine,
due to lack of fit (“Doctors sometimes do not pay attention to or disregard what their patients are
telling them”). Fit statistics are shown in Table 2. CFA models are included in the supplementary
materials (S2, S3).
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Table 1.2. Fit Statistics for Each Measurement Model
Model (Latent Variables)

Model A (Religious Practice, ProVaccine Religious Views, Trust in
Modern Medicine, Vaccine
Knowledge, Positive Attitudes
Toward Vaccines, Intent to
Vaccinate)
Model B (Religious Practice,
Religious Encouragement of
Premarital Abstinence, Beliefs that
Religious Adherence Protects Against
HPV, HPV Knowledge, Intent to
Vaccinate)
Model for Remaining Variables
(Religious Influence, Religious Hope,
Parent/Peer Influence on Sexual
Behavior, Fear of HPV Vaccine Sideeffects)
Combined Model

TLI

CFI

CFI

SRMR

Chi-square Test

351

<.001

.948

.955

.041

.055

𝑋
value
5321.84

.927

.938

.058

.65

4455.42

210

<.001

.966

.973

.041

.045

2699.05

120

<.001

.902

.991

.042

.065

13280.5

1485

<.001

df

3.4 Structural Equation Modeling
SEM on model A shows a robust fit as indicated by fit statistics and probability scores
(see Table 3). The model indicates that respondents with higher religious practice have a slightly
higher intent to vaccinate their children against HPV (+0.158). Respondents with higher religious
practice also had higher vaccine knowledge (+0.639). Vaccine knowledge is not a significant
predictor of intent to vaccinate. Respondents with higher religious practice have a more negative
attitude to vaccines in general (-0.358). Respondents who view vaccines positively have a higher
intent to vaccinate their children (+0.590). Lower attitudes toward vaccination negatively
impacts intent to vaccinate. Respondents who indicated that their religion views vaccines
positively have more trust in modern medicine (+0.615), less vaccine knowledge (-0.245) and
have higher attitudes towards vaccines in general (+0.828). There is not a significant relationship
between trust in modern medicine and intent to vaccinate. There is also not a significant
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p-

relationship between vaccine knowledge and intent to vaccinate. Income positively influences
intent to vaccinate (+0.157).

Table 1.3. Fit Statistics for Each Structural Equation Model.
Model (Latent

TLI

CFI

RMSEA

SRMR

Chi-square Test
𝑋

Variables)

df

p-

value
Model A

.939

.946

.043

.061

5531.44

378

<.001

Model B

.927

.939

.058

.065

4455.42

210

<.001

In model A, a positive attitude toward vaccines in general is the strongest predictor of intent to
vaccinate, religious practice negatively impacts vaccine attitudes, whereas positive religious
views on vaccines positively impacts vaccine attitudes.
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Figure 1.2 Results of Structural Equation Model A. We hypothesize that religious practice and
pro-vaccine religious views affect trust in modern medicine, vaccine knowledge and positive
attitudes toward vaccines, which in turn affects parents’ intent to vaccinate against HPV. Bolded
lines indicate the relationship is significant, the numbers adjacent to the lines indicate the
strength and direction of the relationship. The biggest influence on intent to vaccinate is positive
attitudes toward vaccines (+0.590), which is negatively influenced by religious practice (-0.354)
and positively influenced by the views of respondent’s religion toward vaccines.
SEM on model B also shows a robust fit as indicated by fit statistics and probability
scores (Table 2). The model (Figure 3) indicates that religious practice is a significant predictor
of a belief that religious adherence protects against HPV (+0.542). This belief in turn negatively
impacts intent to vaccinate (-0.164). Respondents with high religious practice have higher
knowledge about HPV (+0.284), which positively impacts intent to vaccinate (+0.784).
Respondents whose religion highly emphasizes abstaining from sex before marriage have
slightly higher knowledge of HPV (+0.194), which positively influences intent to vaccinate
(+0.784). Neither religious practice nor religious encouragement of premarital abstinence has a
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direct impact on intent to vaccinate. Knowledge about HPV is the strongest predictor of intent to
vaccinate; both religious practice and religious encouragement of abstinence before marriage
positively affect knowledge about HPV.

Figure 1.3. Structural Equation Modeling Results Model B Representing the Second Component
of our Hypothesis. We hypothesize that religious practice and religious encouragement of
premarital abstinence affects the belief that religious adherence protects against HPV, and
knowledge about HPV, which in turn both affect intent to vaccinate against HPV. Bolded lines
indicate that a relationship is significant, the numbers adjacent to the lines indicate the strength
and direction of the relationship.
3.4 Univariate Factor Analysis
Univariate correlation analysis was preformed to determine whether belief in vaccine
efficacy and belief in vaccine safety impact respondents’ intent to vaccinate their children
against HPV (Figure 4). There is a strong positive correlation between intent to vaccinate and
belief in vaccine efficacy (r=0.3828, p<0.00001). The magnitude of this effect was a change in
Intent to vaccinate score of 5. These scores rose from a low median of 12 to a high of 17 with
increasing belief in vaccine efficacy. Univariate analysis also indicated that there was a strong
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positive correlation between views on the safety of the HPV vaccine and intent to vaccinate (r=0.3828, p=<0.00001). Intent scores rose from a low of 6 to a high of 14 with increasing
confidence in vaccine safety. For both efficacy and safety scores, there was a plateau effect,
with approximately the top third of scores having the same median values.
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Figure 1.4. Intent to Vaccinate Correlates with Views of Safety and Efficacy: There is a strong
correlation between an individual’s intent to vaccinate their children against HPV and their
beliefs in the safety and efficacy of HPV vaccines. The y-axis indicates intent to vaccinate, the xaxis indicates beliefs in the safety and efficacy of the vaccine. [A] Individuals who believe that
the vaccine is effective have a higher intent to vaccinate their children (r=0.3828, p=<0.00001)
[B] Individuals who believe that the vaccine is safe have a higher intent to vaccinate their
children (r=0.4021, p=<0.00001).
Univariate correlation analysis was preformed to determine whether vaccine knowledge
impacts respondents’ intent to vaccinate their children against HPV (Figure 5). There is a strong
positive correlation between intent to vaccinate and vaccine knowledge (r=0.5297, p<0.00001).
As individuals have increased knowledge about vaccines in general, their intent to vaccinate their
children against HPV increases. Overall intent to vaccinate more than tripled, with median intent
to vaccinate rising from 5 to 19 with increasing knowledge of vaccines.
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Figure 1.5. Intent to Vaccinate Correlates with General Vaccine Knowledge: There is a strong
positive correlation between an individual’s general knowledge about vaccines and their intent to
vaccinate their children against Human Papillomavirus. Larger values on the y-axis indicate a
higher intent to vaccinate against HPV and larger values on the x-axis indicate more general
knowledge about vaccines (r=0.529658, p<0.00001).
4. Discussion
SEM analysis on the first model (Figure 2) shows that income, religious practice, and
positive vaccine attitudes are all predictors of intent to vaccinate against HPV. Positive attitudes
toward vaccines, with a value of 0.590, is a far stronger predictor of intent to vaccinate than
religious practice or income, with values of 0.158 and 0.157, respectively. If an individual has a
generally favorable attitude toward vaccination, it follows that they would choose to consider
current health guidelines and vaccinate their children against HPV. If an individual feels that
vaccines are ineffective or risky it is unlikely that they would choose to vaccinate their children.
Although religious practice has a slight positive impact on intent to vaccinate it has a negative
impact on vaccine attitudes. Positive vaccine attitudes are the strongest predictor of intent, so the
negative effect of religious practice on vaccine attitudes decreases intent to vaccinate. A subset
of our population was highly religious, highly educated and had a high intent to vaccinate, which
explains the slight positive relationship between religious practice and intent to vaccinate. The
relationship between income and intent to vaccinate could be explained by the assumption that
34

individuals with higher income have access to superior healthcare and therefore have better HPV
vaccine access.
SEM analysis on the second model [Figure 3] shows that knowledge about HPV is a
strong predictor of parents’ intent to vaccinate their children against HPV with a value of 0.784.
If parents understand the possible risk presented by HPV infection it is understandable that they
would want to protect their children through vaccination. This interpretation is further supported
by univariate factor analysis, which shows that intent to vaccinate is correlated with belief in the
safety and efficacy of HPV vaccination [Figure 4]. Religious practice is positively related to
vaccine knowledge; this relationship could be explained by the highly religious subset of our
sample who are also highly educated. Religious encouragement of premarital abstinence is
positively related to HPV knowledge.
SEM analysis also shows that the belief that religious adherence protects against HPV is
a negative predictor of intent to vaccinate, with a value of -0.164. Religious parents may feel that
HPV vaccination is unnecessary for their children. Religious parents may also fear that HPV
vaccination could increase their child’s sexual activity, which would negatively impact their
intent to vaccinate if they perceive increased sexual activity as a negative outcome. Although the
relationship between intent to vaccinate and a belief that religious adherence protects you from
HPV was found to be significant, the relationship is not very strong. However, highly religious
individuals are more likely to believe that religious ad-herence and lifestyle protect against HPV
than their less-religious peers. The positive influence of religious practice on this belief could
indirectly reduce respondents’ intent to vaccinate. This could also suggest stigmatization of those
with HPV, as has been seen elsewhere [76].
SEM analysis on the first model did not show a significant relationship between vaccine
knowledge and intent to vaccinate. Univariate analysis shows intent to vaccinate is correlated
with general vaccine knowledge. Although these results may appear to contradict, univariate
analysis is sometimes better at illuminating the relationship between latent variables than SEM
on a complex model. In a complex model the relationships between some variables can be
masked by the interaction of other variables. Understanding how vaccines provide protection
against various diseases and how vaccines are tested to ensure that they are reasonably safe,
could increase confidence in HPV vaccination thereby increasing parental intent to vaccinate.
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These findings clarify some of the earlier work on religiosity and HPV [12-15, 21] by
taking a two-step approach to how religiosity affects vaccination intent. We explored how
religiosity impacts other factors that lead to vaccination decision making, specifically in the
context of Christianity in America. Many of these connections are likely to be applicable beyond
the United States, since the variables concerning religiosity and security are not unique to the
United States. The results could therefore be widely useful wherever religiosity is high and HPV
uptake is low.
Future directions
This work will be the basis for future work looking at targeted interventions geared
towards improving vaccine attitudes among highly religious people. Specifically, these will be
focused on the idea of vulnerability to infection due to a religious expectation of abstinence
before marriage, and on vaccine and HPV knowledge. We will also examine other religious
traditions.
Strengths/limitations
One of the most important strengths of the study is that it was carried out among a
targeted group that has a historically low acceptance of the HPV vaccine. Another strength is that
our computer models were able to determine a path where we could examine the effects of
variables such as religious practice, or religious teaching on sexual behaviors on other variables
that influence vaccine decision making. The ideas we examined can potentially be affected by
public health interventions. One of the primary limitations to the study is that it was difficult to
find people who fit the inclusion criteria who had not finished high school. This suggests a
possible bias in the surveyed population towards more educated, wealthier individuals. Given the
COVID-19 pandemic, this is a time of potential flux in vaccine attitudes, as governments and
individuals incorporate experience with widespread deadly disease, vaccine requirements, and
fatigue for government interventions [77]. Continued research will be necessary to ensure that
our findings remain consistent.
5. Conclusion
The novelty of this work lies primarily in the dissection of the interactions between religious
factors and vaccine attitudes. We were able to find not just associations, but mechanisms through
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which religious practice and teachings about sexuality can affect HPV vaccine attitudes. We
found that the more knowledge individuals have about HPV and the better they understand the
risks presented by HPV infection the higher their intent to vaccinate their children against HPV.
We also found that the individuals who viewed vaccines positively were more willing to
vaccinate their children against HPV.
In addition, individuals who believe that religious adherence provides protection against HPV
have lower intent to vaccinate their children against HPV, which lowers one’s intent to
vaccinate. SEM revealed that this sense of safety, their knowledge about HPV, and their
knowledge about vaccines indirectly, rather than directly, influences intent to vaccinate.
Interventions focused on explaining the risks presented by HPV infection and the benefits of
vaccination could help increase vaccine acceptance and uptake. Interventions should address
general vaccine concerns and highlight testing and safety. Religiosity is associated with the idea
that religious beliefs or behaviors will protect a person’s children from infection with HPV.
Intervention strategies could therefore focus on the dire or fatal consequences of HPV infection
in the event that the children contract the virus, no matter what the circumstances. Other
interventions may focus on the high prevalence of the virus and showing that people with which
this religious group identifies are commonly infected with HPV.
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Table
S1: Survey, Figure S1: Confirmatory factor analysis for model 1, S2: Confirmatory factor
analysis for model 2.
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Chapter 2
Evaluating the Effectiveness of Religious Focused and Educational Video Interventions on
Increasing HPV Vaccine Uptake.
Introduction
Vaccines have drastically reduced the incidence of once common diseases. Smallpox was
eradicated and polio has almost been eradicated through vaccination. Despite the past success of
vaccination programs there has been a resurgence of infectious diseases[78, 79]. A waning of
natural immunity combined with a reduction in vaccination rates due to vaccine hesitancy has
allowed infectious diseases that were once fairly well controlled to spread. In addition to
permitting previously controlled diseases to reemerge, vaccine hesitancy negatively impacts the
effectiveness of newly developed and released vaccines. Effective vaccines have been developed
against high-risk HPV subtypes. These new vaccines have sharply reduced the incidence of the
strains covered by the vaccine in regions with high uptake[66]. Areas with more vaccine
hesitancy have not experienced as much of a decline in HPV rates due to lower vaccine uptake
rates.
Vaccine Hesitancy is a somewhat difficult problem to address. There are many factors
that impact vaccination attitudes including, education, fear of side-effects, misinformation,
relationship with primary care provider etc. We previously identified factors that impact parental
intent to vaccinate their children against HPV. We found that the more knowledge parents have
about HPV and the better they understand the risks presented by infection, the higher their intent
to vaccinate their children against HPV. We also found that parents who feel that religious
adherence provides protection against HPV have lower intent to vaccinate [80]. We designed two
interventions in the form of short educational films. We then tested the effectiveness of these
interventions using a survey
Survey Description
The survey was composed of 4 sections. The survey section was demographic
information. The second section of the survey assessed participant views and attitudes preintervention including subsections assessing knowledge about HPV, general vaccine attitudes,
religiosity, views on sex, and attitudes towards modern medicine. The third section of the survey
was an embedded intervention video. There are three intervention videos which were randomly
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assigned to participants. The first video was a control and contained information on an
adenovirus. The second video was a religious intervention and contained an interview with a
religious cervical cancer survivor who discussed her experiences and advocated for getting
vaccinated. The third video was an educational intervention and contained scientific facts about
human papillomaviruses, the diseases they cause, how they are transmitted, and how vaccination
protects against them. The final section of the survey assessed participants views and attitudes
post-intervention and repeated the questions contained in the second section.
Results
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Figure 2.1 Population Demographics: Most (83.8%) of our survey participants were between 25
and 45 years old. This is reasonable age range because of our selection criteria was parents with
children younger than 11 who identify as Christian. Our population is predominantly white, but
all ethnicities were represented. The average number of children that survey participants have is
2. The majority (65%) of our sample population is female. The majority (62.3%) of participants
are married, this is somewhat higher than the national average but not unusual based on our
selection criteria. Less than half (57.86%) of our population have completed a college degree.
The level of education is fairly representative of the national education level. The national
median household income ~$67,000, so our sample income is also fairly representative of the
national average.
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Figure 2.2 Approximate Geographical Distribution of Survey Respondents: Approximate latitude
and longitude were collected automatically from survey participants. This data was used to plot
the approximate location of participants. There are regional differences in HPV vaccine uptake
with some states consistently reporting low vaccination rates. The geographical distribution of
our respondents mirrors the population density of the United States where the east is much more
populous and the population in the west is clustered around a handful of cites.
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Figure 2.3 Change in Intent to Vaccinate Post Intervention: Responses for the six survey items
representing the latent variable “Intent to vaccinate” were summed to determine if participants
were Accepting, Neutral or Hesitant about HPV vaccinations. Post-intervention attitudes were
also calculated. Three graphs were created for the different interventions based on preintervention attitudes. Most survey participants did not have a change of attitude postintervention. The Religious and educational interventions appear to be more effective at
increasing intent to vaccinate than the control. Participants where initially vaccine hesitant were
most likely to change attitudes post intervention.

Figure 2.4: Alluvial Diagram Displaying Change in Intent (Control Intervention). Survey
participants were asked to indicate how the felt about the statement “I am likely to vaccinate my
children against HPV OR I have already vaccinated my eligible children against HPV.” before
and after viewing the intervention video. This figure shows participants who viewed the control
video which contained facts about adenovirus. Data for participants who indicated no change in
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attitude were removed for this figure. The colors correspond to participant attitudes post
intervention. The control intervention has somewhat mixed results.

Figure 2.5: Alluvial Diagram Displaying Change in Intent (Religious Intervention). Survey
participants were asked to indicate how the felt about the statement “I am likely to vaccinate my
children against HPV OR I have already vaccinated my eligible children against HPV.” before
and after viewing the intervention video. This figure shows participants attitudes after viewing
the religious intervention video. Data for participants who indicated no change in attitude were
removed for this figure. The religious intervention appears to have had a positive effect on
participants who already agreed with the statement strengthened their intent to vaccinate. The
intervention also appears to have been effective on at increasing intent to vaccinate in a portion
of participant who were neutral, disagreed, or strongly disagreed before with the statement.
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Concernedly the largest portion of participants with low intent to vaccinate post intervention had
high intent to vaccinate before the intervention.

Figure 2.6: Alluvial Displaying Change in Intent. Survey participants were asked to indicate how
the felt about the statement “I am likely to vaccinate my children against HPV OR I have already
vaccinated my eligible children against HPV.” before and after viewing the intervention video.
This figure shows participants who attitudes after viewing the educational intervention. This
intervention appears to be somewhat effective at improving the intent of participants who had
neutral views before viewing the intervention. More than half of the participants who strongly
disagreed with the statement before the intervention indicated that they agree or strongly agreed
after the intervention which is very positive.
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Chapter 3
Utah Parents Displaying Cautious Sexual Attitudes have Lower Intent to Vaccinate their
Children Against HPV then Their less Cautious Peers.
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1. Department of Microbiology and Molecular Biology, Brigham Young University, Provo,
UT, USA
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Abstract
Although most Human papillomavirus (HPV) infections are mild and are cleared
relatively quickly by the immune system some high-risk HPV strains can cause various cancers.
Vaccines have been developed which protect against high-risk HPV strains. HPV vaccines have
been approved for use by the CDC (Centers for Disease Control and Prevention) and are
recommended for everyone age 11-26. Despite the availability of safe and effective vaccines
uptake is low. HPV vaccine uptake has been extensively studied on a national and international
level, but less is known about vaccine acceptance on a state or local level. In this study we
identified factors that impact the intent of Utah parents to vaccinate their children against HPV.
A survey was distributed electronically to Utah residents. Survey results were analyzed using
confirmatory factor analysis, structural equation modeling, and univariate analysis. Knowledge
about HPV and positive vaccine attitudes had the greatest positive effect on intent to vaccinate
children against HPV. Cautious sexual attitudes and high religious practice were found to have a
negative impact on intent to vaccinate. Overall, our sample population viewed HPV vaccination
positively.
1. Introduction
Human papillomaviruses (HPV) are a family of over 150 related human viruses. HPV are
non-enveloped double stranded DNA viruses. HPV have co-evolved with humans over millions
of years, and are therefore well adapted, often causing cause minimal symptoms or are
completely asymptomatic [44]. HPV infects cutaneous and mucosal stratified epithelial cells. In
order to replicate, HPV promotes cell cycle progression within infected cells. Modulation of the
cell cycle can cause increased cell proliferation resulting in growths called warts or papillomas
[46]. Although most HPV infections are mild and typically clear on their own within a few
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months to a few years, persistent HPV infections are strongly associated with the development of
various cancers [45, 81]. HPV causes 99% of cervical cancers, 90% of anal cancers 50% - 65%
of vulvar and vaginal cancers, and between 45% and 90% of oropharyngeal cancers [82]. HPV is
responsible for approximately 5% of the world’s total cancer burden [62].
HPV is the most commonly sexually transmitted infection. Between 50-80% of
individuals will be infected with HPV sometime during their life [45, 61]. HPV is generally
transmitted through skin to skin or sexual contact. Although HPV is generally sexually
transmitted evidence suggests that HPV can also be transmitted on surfaces or medical
implements [82]. HPV is resistant to many common clinical disinfectants and can remain active
on surfaces even after cleaning [49].
Due to the potential harm that HPV can cause, significant effort was made to develop
preventative vaccines. Three vaccines have been approved for use in the United States by the
Food and Drug administration (FDA). All three vaccines provide protection against the
oncogenic HPV strains 16 and 18, which are responsible for 70% of HPV induced cervical
cancers [45]. Multiple studies have shown that HPV vaccines are safe for human use, and
effective at reducing infection with high-risk HPV strains. [62]. There has been measurable
reduction in the incidence and transmission of HPV strains covered by vaccines [52, 83].
Despite the effectiveness of HPV vaccines at preventing HPV infection and progression
into various cancers, vaccine uptake is low. In 2018 global HPV vaccine uptake was estimated
12.2% for 15 year-old females. Significant variation in vaccination rates was observed between
wealthy and developing nations, with wealthy nations reporting higher vaccination rates [84].
Although HPV vaccination rates in the United States are higher than the global average, vaccine
uptake has been modest. A 2016 study reported that 60% of adolescents 13-17 have received at
least 1 vaccine dose and that only 37% have completed the vaccine series [85]. Young adults
(18-26) have an even lower vaccination rate than adolescents. The US department of health and
Human Services (HHS) estimates that half of young adults have received at least 1 vaccine dose
and less than 22% have completed a vaccine series [69].
There have been many studies assessing HPV vaccine uptake at a national level but there
is has been little research done about what impacts HPV vaccination rates at a state level. For the
past 5 years, the percentage of Utah adolescents who have received the recommended number of
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HPV vaccine doses has been persistently among the lowest in the country [60, 84]. The studies
on HPV vaccination in Utah that have been performed focused primarily on health care
providers. [86, 87]. In one of these studies health care providers consider parental
misconceptions to be the strongest barrier to HPV vaccination in Utah [59]. Another Utah study
found that religious young women are underinformed about HPV and are under-vaccinated [59].
To better understand what factors, impact parental intent to vaccinate their children we surveyed
Utah parents directly.
2. Materials and Methods
2.1 Survey of Utah Residents.
Utah residents were invited to participate in a cross-sectional study by completing a
survey designed to assess attitudes toward HPV vaccination. The survey was distributed through
an online portal by Qualtrics (Provo, UT, USA). Initial inclusion criteria required participants to
be a current resident of Utah. Survey results were later filtered so only parents, with a child 15 or
under, were included in our sample. Filters were applied to collect responses from educational
backgrounds consistent with census data for Utah.
2.2 Survey Description
The survey contained 80 questions in total. Some questions were clarifying questions and
were only shown if certain responses were chosen on previous questions. The questions were
divided into 10 sections. The first section contained questions about demographics. The second
section assessed primary sources of news. The third section and fourth sections assessed trust in
government and modern medicine respectively. In the fifth section participants were asked about
their religious practice. The sixth section assessed aspirations for their children. In the seventh
section, participants were asked about their sexual attitudes and what they intended to teach their
children about sex. The eighth section assessed knowledge about HPV. The ninth section
assessed participants attitudes towards vaccines in general. The final section contained outcome
questions which tested the attitudes of parents toward HPV and their intent to vaccinate their
children against it. Prior to distribution the study received ethical approval from the institutional
review board of Brigham Young University (IRB# IRB2022-165).
2.3 Confirmatory Factor Analysis and Structural Equation Modeling
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To validate our survey, confirmatory factor analysis (CFA) was used to confirm the latent
variables we were testing were accurately represented by the questions we chose to include in the
survey. We preformed structural equation modeling (SEM) to test the relationship between
variables. Before starting analysis we cleaned and organized the data using Excel (Microsoft
2022 Redmond, WA, USA) and SPSS statistics software (IBM 2021 Armonk, NY, USA). The
first step of cleaning the data was removing participants who indicated that they did not have
children, because we wanted to look at what factors impacted parental intent to vaccinate their
children. Next we removed data determined to be incomplete or low quality. Mplus software,
ver 8 (Muthen and Muthen, 1998-2001, Los Angeles, CA, USA) was used to perform CFA and
SEM on the measurement and structural portion of our model. Latent variables were represented
by three or more survey items. CFA was performed with a request for modification indices.
Survey items representing latent variables were removed until fit indices (root mean square error
approximation), comparative fit index (CFI), Tucker-Lewis index (TLI) and standardized root
mean square residual (SRMR)) were found to be acceptable. SEM was performed on a complete
model comprised of all the validated latent variables with age, gender, income and education as
covariates. The validated latent variables were divided to form two hypothetical models, the first
to test the relationship between trust in medical professionals and religious practices on intent to
vaccinate through general vaccine attitudes; and the second to test the relationship between
knowledge of HPV and religious practice on intent to vaccinate through sexual attitudes; SEM
was performed on the hypothetical models.
2.4 Univariate Analysis
Univariate analysis and data visualization were preformed to further explore the factors
that impact intent to vaccinate identified by structural equation modeling. To illustrate our
sample populations attitude toward HPV vaccination we created stacked bar charts of our
outcome variables using the likert, tidyverse and ggplot2 libraries in R. We used the corrplot and
psych R libraries to create a series of correlation matrixes to determine which variables were
correlated with intent to vaccinate. We created count plots to display individual correlation
between intent to vaccinate and variables identified using correlation matrixes. The R code used
to analyze data and create the figures is available in our supplementary materials.
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3. Results
3.1 Demographic Characteristics of Survey Respondents
We summarized demographic characteristics of our sample (Table 1), before beginning
formal analysis of our dataset. We selected our dataset so that only respondents with children
were included. Most respondents had 1 or 2 children (68.5%) The vast majority of respondents
were between 26 and 45 years old (82%). Approximately one third of our sample identified as
male (31.1%) and two thirds identified as female (68.9%). Participants had the ability to select
“Non-binary/third gender” or “I prefer not to answer” for Gender, 1 participant declined to
answer and no participants selected Non-binary/third gender choices were removed from the
table for clarity. The vast majority of participants selected white (83%) as their ethnicity. More
than half of the participants indicated that they were married (68.4%). Almost all of the
participants in our study have completed high school (97.5%) but less then half have completed a
college degree (44.65%). A vast majority of participants of our participants have a yearly
household income less than $100,000 (82.4%). In our sample 37.6% participants identified as
republican, 33.5% identified as independent, and 19.0% identified as Democrat. Political
leanings on social issues had a relatively even distribution, with the largest portions (36.7) of
respondents indicating that they are neither liberal nor conservative leaning. A majority of
respondents in our sample indicated they were Christian (57.81%) the second largest group
indicated that they had no religious affiliation (27.67%)
Table 3.1. Demographic Characteristics
Range
Number of Children
1
2
3
4
More than 4
Age
18‐25
26‐35
36‐45
46‐55
Over 55
Gender
Male

Number
n = 365
134
116
64
33
18
n = 365
23
144
155
33
10
n = 363
113

Percent of total responses
36.7%
31.8%
17.5%
9.0%
4.9%
6.3%
39.5%
42.5%
9.0%
2.7%
31.1%
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Female
Ethnicity
American Indian or Alaskan native
Asian
Black or African American
Latino or Hispanic
Pacific Islander or Native Hawaiian
White
Two or More
Other/Unknown
I prefer not to answer
Marital Status
Single
Married
Partnered (non‐married)
Divorced
Widow/Widower
Other
Education
Have not completed High School
Finished High School
Some College
Associates degree
Bachelors degree
Post‐baccalaureate/professional degree
Yearly Household Income
Less than $25,000
$25,000 ‐ $50,000
$50,000 ‐ $100,000
$100,000 ‐ $150,000
$150,000 ‐ $200,000
More than $200,000
Political affiliation
Democrat
Republican
No political affiliation
I prefer not to answer
Other
Political leanings on social issues
Very Liberal
Liberal
Somewhat Liberal
Neither Liberal nor Conservative
Somewhat Conservative
Conservative
Strongly Conservative
Religious Affiliation

250
n=365
2
10
3
30
8
303
5
2
2
n = 364
46
249
27
33
6
3
n = 365
9
92
100
41
84
38
n = 364
46
97
157
48
15
1
n = 364
69
137
122
27
9
n = 365
25
29
37
134
61
54
25
n = 364

68.9%
0.55%
2.74%
0.82%
8.22%
2.19%
83.01%
1.37%
0.55%
0.55%
12.64%
68.41%
7.42%
9.07%
1.65%
0.82%
2.47%
25.48%
27.40%
11.23%
23.01%
10.41%
12.64%
26.65%
43.13%
13.19%
4.12%
0.27%
19.0%
37.6%
33.5%
7.4%
2.5%
6.8%
7.9%
10.1%
36.7%
16.7%
14.8%
6.8%
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Buddhism
Christianity
Hinduism
Islam
Judaism
Other
No Religious Affiliation

2
211
3
1
3
43
101

0.82%
57.81%
0.82%
0.27%
0.82%
11.78%
27.67%

3.2 Confirmatory Factor Analysis
CFA models were run for the latent variables included in the hypothetical structural models used
for SEM. Items 4.1.1 (“I always vote in national elections”) and 4.1.2 (“I always vote in local
elections”) were removed from the latent variable “trust in government” because they measured
whether participants vote rather than their trust in government. Two items were removed from
the latent variable “trust in health professionals” due to lack of fit (5.1.3 “Natural remedies such
as essential oils are as effective at treating most conditions as prescription drugs” and 5.1.5
“Natural remedies are often a better treatment for minor ailments than modern medicine”). No
items were removed from “religious practice.” The questions included in “aspirations for
children” do not form a single latent variable and therefore were not included in CFA or SEM.
Items 8.1 (“As a parent, I emphasize certain rules or cautions about sexual behavior”) and 8.6
(“Sexually transmitted infections are very concerning to me”) did not fit with the latent variable
“cautious sexual attitudes” and were therefore removed. Item 9.1.3 “HPV causes cancer in
women but not men” was removed from the latent variable “high HPV knowledge” due to lack
of fit. Survey item 9.2 (“Vaccines often have severe side effects”) was removed from the latent
variable “Positive vaccine attitudes” due to lack of fit. All the items used to determine “intent to
vaccinate”, fit the model with acceptable fit statistics (see Table 2; Figure 1).
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Figure 3.1 Hypothetical Structural Models: (A) We hypothesize that trust in health professionals
and high religious practice influence positive vaccine attitudes which in turn influences intent to
vaccinate. We also hypothesize that trust in health professionals and high religious practice may
influence intent to vaccinate directly. (B) We hypothesize that high HPV knowledge and high
religious practice influence cautious sexual attitudes which in turn influences intent to vaccinate.
We also hypothesize that high HPV knowledge and high religious practice could influence intent
to vaccinate directly. (C) We hypothesize that the latent variables trust in government, trust in
health professionals, high religious practice, cautious sexual attitudes, high HPV knowledge, and
positive vaccine attitudes may directly influence intent to vaccinate. We also hypothesize that the
covariates age, gender, income, education and political leanings may impact intent to vaccinate.
Table 3.2: Fit Statistics for Full Measurement Model
Model (latent variables)

TLI

CFI

RMSEA

SRMR

χ2

Combined model

0.886

0.900

0.057

0.076

887.029

Chi-square
test df
408

3.3 Structural Equation Modeling
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pValue
<.001

All the Latent variables verified by CFA were combined into a single model with the
covariates income, education, age, gender, and political leanings on social issues (Figure 2).
SEM on the combined model shows a robust fit, as indicated by fit statistics and probability
scores (see Table 3) Structural equation modeling was used to determine which covariates and
latent variables influenced intent to vaccinate in the combined model. The combined model
indicates that respondents with more cautious sexual attitudes have lower intent to vaccinate (0.199). The model also indicates that participants with high knowledge about HPV and positive
attitudes towards vaccination have a higher intent to vaccinate (0.282, 0.553, respectively)
Positive vaccine attitudes had the greatest effect on intent to vaccinate of all the latent variables
tested in the combined model. In the combined model there is not a significant relationship
between trust in government, trust in health professionals, high religious practice, and intent to
vaccinate. The covariates age, gender, income, education, and political leanings on social issues
did not significantly impact intent to vaccinate in the combined model.
Table 3.3. Fit Statistics for Structural Equation Models
Model (Latent variables)

TLI

CFI

RMSEA

SRMR

χ2

Combined model
Model A
Model B

0.885
0.916
0.928

0.902
0.929
0.943

0.050
0.070
0.071

0.067
0.062
0.055

1013.133
398.635
268.436

Chi-Square
test df
528
143
95
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pValue
<.001
<.001
<.001

Figure 3.2: Full Structural Model. Latent Variables and Covariates were combined into a full
structural model. Structural equation modeling was performed to determine which factors impact
parental intent to vaccinate their children against HPV. More cautious sexual attitudes lead to
lower intent. Higher knowledge about HPV leads to higher intent to vaccinate. The more
positively parents view vaccines the higher their intent to vaccinate their children against HPV.
All other Latent variables and covariates were not significantly predictive of intent to vaccinate
in the full structural model.
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SEM on model A shows a robust fit, as indicated by fit statistics (see Table 3). The model
(figure 4) indicates that high trust in health professionals leads to more positive vaccine attitudes
(+0.620) which increases intent to vaccinate (+0.665). The indirect effect through positive
vaccine attitudes explains 96% of the effect of trust in health professionals on intent to vaccinate.
High religious practice does not affect general vaccine attitudes, but it does have a direct
negative impact on intent to vaccinate against HPV. This indicates that in our sample, high
religious practice impacts general intent to vaccinate and intent to vaccinate against HPV
differently.

Figure 3.3: Trust in Medical Professionals is Predictive of Intent to Vaccinate by Means of
Increased Trust in Vaccines in General. The latent variables “Trust in Health Professionals”,
“High religious practice”, “Positive vaccine attitudes”, and “Intent to vaccinate” were combined
in a structural model. Trust in health professionals leads to more positive vaccine attitudes,
which increased intent to vaccinate. High religious practice does not affect general vaccine
attitudes, but it does have a direct negative impact on intent to vaccinate against HPV.
SEM on Model B also shows a robust fit, as indicated by fit statistics (Table 3). The
model (Figure 4) indicates that higher knowledge about HPV has no effect on sexual attitudes
but does directly impact intent to vaccinate against HPV. In this model the impact of religious
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practice on intent to vaccinate against HPV which was shown in the previous model was found
to be mediated through the effect of high religious practice on cautious sexual attitudes (+0.591)
which negatively impacts intent to vaccinate (-0.215). In other words, the higher a participant’s
religious practice, the more cautious they are about sex, and the more cautious they are, the less
likely they are to vaccinate against HPV. The indirect effect of cautious sexual attitudes explains
99% of the impact of religious practice on intent to vaccinate against HPV.

Figure 3.4: Cautious Sexual Attitudes Negatively Impact Intent for HPV Vaccination. The latent
variables “High HPV Knowledge”, “High Religious Practice”, “Cautious Sexual Attitudes” and
“Intent to vaccinate” were combined in a structural model. Higher HPV knowledge has no
significant effect on sexual attitudes but does directly impact intent to vaccinate. Religious
practice does not directly impact intent to vaccinate when combined with the other latent
variables in this model. Religious practice influences sexual attitudes which negatively
influences intent to vaccinate.
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3.4 Univariate analysis

Figure 3.5: Outcome Variables. Five survey items were used to measure attitudes toward the
HPV vaccine and intent to vaccinate. The majority of respondents agree with the statements “I
intend to vaccinate my children against HPV OR I have already vaccinated my children against
HPV”, I will (or would) vaccinate both my sons and my daughters against HPV”, and
“vaccination would protect my children against HPV infection in the case of sexual assault”. The
majority of respondents disagreed with the statements “The potential side effects of the HPV
vaccine will prevent me from vaccinating my children against HPV’, and “Because HPV is
sexually transmitted I will not vaccinate my children against it.
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To determine which factors impacted intent to vaccinate a correlation matrix was created from
the complete survey. Survey items were compared to question 11.1.1“I intent to vaccinate my
children against HPV OR I have already vaccinated my children against HPV” which was used
to represent parental intent to vaccinate their children against HPV. Questions 11.1.2, 11.1.3,
11.1.4, and 11.1.5 were excluded from analysis because they belong to the same latent variable
as question 11.1.1 and are therefore highly correlated. . Seven survey items were determined to
be individually correlated with intent to vaccinate (figure 5).

Figure 3.6: Survey Items Correlated With Intent to Vaccinate. A correlation matrix of the
complete survey was created. Non-significant results and results with a low degree of correlation
were removed to create an abbreviated correlation matrix. Blue coloration indicates a positive
correlation with question 11.1.1 “I intend to vaccinate my children against HPV OR I have
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already vaccinated my children against HPV”, purple indicates a negative correlation, blank cells
indicate that a result was not significant.
Table 3.4. Survey Items Moderately Correlated with Intent to Vaccinate
Question Text

PCC

P-Value

4.1.7

0.31

<0.0001

0.31

<0.0001

0.29

<0.0001

10.1.1

The HPV vaccine is effective at preventing almost all cancers
caused by HPV
Vaccines are more helpful than harmful

0.30

<0.0001

10.1.4

Vaccines are extensively tested to ensure their safety

0.38

<0.0001

10.1.5

Vaccines contain dangerous toxins

-0.31

<0.0001

10.1.7

Vaccination efforts have considerably reduced the
transmission of infectious diseases in the United States

0.30

<0.0001

8.2
9.1.4

I trust in public health guidelines provided by the CDC
(Centers for Disease Control and Prevention)
Sexual education is a necessary part of school curriculum

Figure 3.7: Intent to Vaccinate is Positively Correlated with Trust in Public Health Guidelines.
[A] A majority (53.5%) of respondents agree or strongly agree with the statement “I trust in
public health guidelines provided by the CDC (Centers for Disease Control and Prevention)” [B]
Linear regression comparing survey item 4.1.7 trust in CDC public health guidelines with item
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11.1.1 intent to vaccinate children against HPV. Responses were scored on a Likert scale where
one indicates “Strongly Agree” and five indicates “Strongly Disagree”. The graph shows a
positive correlation (0.317) between trusting in CDC public health guidelines and intent to
vaccinate.

Figure 3.8: Intent to Vaccinate is Positively Correlated with Views that Sexual Education is
Important. [A] A majority (72.8%) of respondents agree or strongly agree with the statement
“Sexual education is a necessary part of school curriculum” [B] Linear regression comparing
survey item 8.2 sexual education is a necessary part of school curriculum with item 11.1.1 intent
to vaccinate children against HPV. Responses were scored on a Likert scale where one indicates
“Strongly Agree” and five indicates “Strongly Disagree”. The graph shows a positive correlation
(0.307) between views that sexual education is necessary and intent to vaccinate.
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Figure 3.9: Intent to Vaccinate Positively Correlated with Views that the HPV Vaccine is
Effective at Preventing Some Cancers. [A] A majority (62.2%) of respondents agree or strongly
agree with the statement “The HPV vaccine is effective at preventing almost all cancers caused
by HPV”. [B] Linear regression comparing survey item 9.1.4 the HPV vaccine prevents almost
all cancers caused by HPV, with item 11.1.1 intent to vaccinate. Responses were scored on a
Likert scale where one indicates “Strongly Agree” and five indicates “Strongly Disagree”. The
graph shows a positive correlation (0.245) between views that the HPV vaccine prevents almost
all cancers caused by HPV and intent to vaccinate.
4. Discussion
4.1 General Attitudes Toward Vaccines are Predictive of Intent to Vaccinate.
In both the combined structural model and partial structural model A, positive vaccine
attitudes are the greatest predictor of intent to vaccinate (Figure 2, Figure 3). Correlation matrix
analysis supports this finding; survey items 10.1.1, 10.1.4, 10.1.5, and 10.1.7, which makeup the
latent variable “positive vaccine attitudes”, were all correlated with intent to vaccinate. (Figure
5) Both structural equation modeling and correlation matrix analysis show that positive vaccine
attitudes increase parental intent to vaccinate against HPV, which is consistent with previous
findings. In a previous study on Christian parents completed by our lab, we found that positive
attitudes toward vaccines were the greatest predictor of parental intent to vaccinate their children
against HPV[80]. Parents who already feel positively about vaccines are probably comfortable
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giving their children all vaccines which are recommended by the CDC even if they do not feel
that their children have a very high risk of contracting high-risk HPV. It also follows that parent
who feel less positively about vaccines would have lower intent to vaccinate their children
against HPV especially if they don’t feel that HPV poses a very high risk to their children. If
parents who feel positively about vaccines have concerns about the HPV vaccine they are more
likely than their vaccine hesitant peers to seek information from authoritative sources such as the
CDC website or discuss their concerns with a pediatrician and/or primary care provider. In
partial model A, trust in healthcare professionals positively impacts vaccine attitudes, which
increases intent to vaccinate. The indirect effect of trust in healthcare professionals through
positive vaccine attitudes explains 96% of trusts influence on intent to vaccinate, which means
trust in healthcare professionals has an indirect effect on intent to vaccinate by influencing
positive attitudes. Parents who trust in their primary care providers are probably more likely to
follow their recommendations and get their children vaccinated against HPV. Because HPV
vaccines are relatively new, parents may not be aware that they exist and of the benefits they
provide; If primary care providers have a good relationship with parents they will have an easier
time educating and recommending HPV vaccination.
4.2 High Religious Practice Negatively Impacts Intent to Vaccinate by Influencing Sexual
Attitudes.
In structural model A (Figure 3), high religious practice was seen to negatively impact
intent to vaccinate against HPV. Structural model B (Figure 4) explains this effect by showing
that high religious practice positively influences cautious sexual attitudes which negatively
impacts intent to vaccinate. The indirect effect of high religious practice through cautious sexual
attitudes explains 99% of the variance, this means that 99% of the negative impact of high
religious practice on intent to vaccinate is due to the influence of high religious practice on
cautious sexual attitudes. Parents with cautious sexual attitudes may not feel that it is necessary
to vaccinate their kids against HPV because the vaccine only protects against sexually
transmitted strains, and they may feel like the risk of their Children contracting sexually
transmitted HPV is low. Alternatively, parents who have cautious attitudes toward sex may not
do much research on sexually transmitted diseases and consequently not be aware of harm HPV
infection can cause. The Church of Jesus Christ of Latter-day Saints (LDS), which is the
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predominant Church in Utah, advocates for sexual abstinence before marriage and fidelity within
marriage [88]. The LDS Church’s stance on sexual relations could partially explain why parents
in our study with high religious practice had more cautious sexual attitudes. A significant portion
of our population identified as LDS and are therefore more likely to be cautious about sex and
encourage their children to abstain from sex until marriage.
4.3 Knowledge about HPV Increases Intent to Vaccinate, and sex Education can Increase HPV
Knowledge
High HPV knowledge was shown to be predictive of intent to vaccinate in the complete
structural model and in partial structural model B (Figure 2, Figure 4). This shows that in our
sample parents who understand the risks of HPV infection intend to protect their children against
HPV through vaccination. Educating parents and caregivers about HPV may be an effective
mechanism for increasing intent to vaccinate and increase overall HPV vaccination rates. In our
study we observed that a majority (72.8%) of respondents agree or strongly agree with the
statement “Sexual education is a necessary part of school curriculum.” Intent to vaccinate is also
positively correlated with belief that sexual education is a necessary part of school curriculum
(figure 8). Knowledge of HPV is a predictor of intent to vaccinate, and sexual education in a
medium whereby information about HPV can be delivered. Sexual education curriculum usually
focusses on reducing the risk of pregnancy and infection through education. If parents feel that
sexual education is a necessary part of school curriculum, it follows they are fairly aware of the
risks that their children may encounter and strive to protect their children through various means
including education and vaccination.
4.4 HPV Vaccination is Viewed Positively in our Sample Population.
A majority (70%) of our sample agree or strongly agree with the statement “I intend to
vaccinate my Children against HPV or I have already vaccinated my children against HPV”
(Figure 5). This is a promising outcome because it shows that there is high intent in our
population to vaccinate against HPV. The HPV vaccine was originally only recommended for
females, the CDC later changed their recommendation to include everyone. Seventy one percent
of our sample indicated that they would vaccinate both their sons and their daughters. this
indicates that the initial recommendation that the HPV vaccine only be administered to females
does not impact current intent of parents to vaccinate all their children. The eight percent of
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respondents who disagreed with the statement “I will (or would) vaccinate both my sons and
daughters against HPV” likely do not intend to vaccinate any of their children against HPV for
reasons unrelated to gender. Half of our sample indicate that they would vaccinate their children
despite potential side effects. This could indicate that they feel that HPV presents a far greater
risk to their children then the potential risk posed by receiving the vaccine. Thirty-one percent of
respondents indicated that they neither agree nor disagree with the statement "The potential side
effects of the HPV vaccine will prevent me from vaccinating my children against HPV.” Most
parents do not know the frequency of adverse reactions to the HPV vaccine. Uncertainty about
the frequency of adverse reactions could explain why a large portion of the sample is unsure if
they agree or disagree with the statement about vaccinating their children despite potential side
effects. Educating parents about the potential risks of vaccination and the frequency of adverse
effects could help increase vaccination rates as they learn that adverse reactions are uncommon,
and the risk of potential side effects is low.
4.5 Trust in Health Guidelines Increases Intent to Vaccinate
A majority (53.5%) of survey participants agree or strongly agree with the statement “I
trust in public health guidelines provided by the CDC”. Trust in CDC public health guidelines is
also positively correlated with intent to vaccinate (Figure 7). As of June, 2022, the Centers for
Disease Control and Prevention (CDC) recommends that everyone be vaccinated against HPV at
age 11-12. The CDC also recommends vaccination for everyone 26 and younger who were not
adequately vaccinated when they were younger. Vaccination can be administered after 26 for
high-risk individuals, or on the recommendation of a clinician [89]. Most HPV infections are
mild and rarely cause life threatening complications therefore few parents are worried about their
children contracting HPV. There is little discussion or public awareness about HPV and societal
pressure supporting vaccination is low, therefore institutions like the CDC are often the only
organizations promoting HPV vaccination. Because the CDC is the national agency responsible
for health in the United States, trust in the CDC can reflect a broader trust in research and
medical institutions. Trust in public health guidelines such as vaccine recommendations from the
CDC can directly impact intent to vaccinate because the CDC and state and local health
departments are often the only organizations encouraging people to get vaccinated against HPV
4.5 Belief that Vaccination Protects Against HPV Induced Cancer, Increases Intent to Vaccinate
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There is a positive correlation between intent to vaccinate and the belief that the HPV
vaccine is effective against preventing HPV induced cancer. This observation is consistent with
the Health Belief Model, which is that if the perceived benefits are high (the prevention of
cancer), the desire to perform the behavior (intent to vaccinate) is also high. Interestingly, only
15.1% of participants strongly agreed that the HPV vaccine prevents cancer, suggesting the lack
of certainty about the causation and prevention of cancer. It is possible that if this sample was
more educated about the ability of HPV to cause cancer, the intent to vaccinate would be higher.
5. Conclusion
In this study we were able to identify factors that influence the intent of Utah parents to
vaccinate their children against HPV, and we were also able to determine the mechanisms by
which these factors affect intent. This study shows that in Utah, positive attitudes about vaccines
in general and knowledge about HPV have the greatest positive impact on the intent of parents to
vaccinate children against HPV. We also found that high religious practice and cautious sexual
attitudes have a negative impact on parental intent to vaccinate.
Parents who already feel positively about vaccination view the HPV vaccine as an
effective method of protecting their kids from HPV, trust in health care professionals increased
positive views of vaccination which increases intent to vaccinate. Parents who are
knowledgeable about HPV understand the risks presented by infection which increases their
intent to vaccinate and protect their children from infection. Parents with cautious sexual
attitudes may feel that their children are unlikely to be exposed to the sexually transmitted strains
of HPV that vaccines protect against, therefore they may feel that it is unnecessary to vaccinate
their children against HPV. High religious practice has a negative effect on intent to vaccinate
because of its considerable impact on cautious sexual attitudes.
Interventions focused on educating Utah residents about the risks HPV infection poses
could improve HPV vaccine uptake. Interventions focused on addressing general concerns about
vaccines would likely also improve HPV vaccine uptake.
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Summary
The results of three Cross-sectional studies are illustrated in this manuscript. In the first
study we investigated what factors influenced intent to vaccinate in Christian parents. We
determined that general vaccine attitudes have the greatest impact on parental intent to vaccinate.
Using random forest analysis, we also found High vaccine knowledge is predictive of positive
intent to vaccinate. We also found that individuals who feel that religious adherence protects
against HPV have lower intent to vaccinate.
We designed interventions in the form of short educational videos based on our findings
in the first study. We designed an education focused intervention and a religious focused
intervention. We tested the effectiveness of this intervention with a second cross-sectional study.
In the study we assessed intent to vaccinate both pre and post intervention. We found that the
religious-focused intervention and the education-focused had a more positive impact on intent to
vaccinate then the control intervention.
In the third study we investigated what factors influenced what factors impacted Utah
residents’ intent to vaccinate. We found that positive vaccine attitudes are predictive of intent to
vaccinate confirming our earlier study. We found that high religious practice had a negative
impact on intent to vaccinate. Through further investigation we were able the determine why
high religious practice and intent to vaccinate are negatively correlated; high religious practice is
correlated with careful sexual attitudes which has a negative impact on intent to vaccinate.
Parents who encourage their children to be careful about sex feel that their children have a lower
chance of contracting HPV.
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